Skip to main content
Clinical Trials/NCT02829866
NCT02829866
Completed
N/A

THP AMIStem-H: Open, Retrospective and Prospective, Monocentric, Non Randomised Observational Study

Medacta International SA1 site in 1 country289 target enrollmentSeptember 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Arthroplasty
Sponsor
Medacta International SA
Enrollment
289
Locations
1
Primary Endpoint
Radiological analysis of radiolucency lines presence according to Gruen zone classification
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Total hip replacement (THP) is widely used for hip osteoarthritis treatment. Surgeons are constantly looking to improve all aspects related to this procedure weather is improvement of implant design, instrumentation or surgical technique. Excellent clinical and radiological results were observed at medium and long term in the last years for AMIStem system.

This observational study has the objective to survey hip prosthesis stability and function of the operated hip in patients who are not exposed to surgical risks. The principal investigator will contact all patients in order to perform the follow-up visit according to standard practice. Patients operated between January 2010 and December 2011 will be invited in the study during the clinical visit organised according to standard practice. Preoperative clinical and radiological data, intraoperative details and postoperative follow-up data at 1-year will be retrospectively collected. Five-year and ten-year data will be prospectively collected after inclusion in the study.

Registry
clinicaltrials.gov
Start Date
September 2010
End Date
October 2021
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient who has received a total hip arthroplasty between January 2010 and December 2011
  • Patient who has received an AMIStem H femoral component
  • Patient who have signed the information letter in order to give agreement for the clinical data treatment

Exclusion Criteria

  • Minor patient
  • Pregnant or breast feeding woman
  • Any patient who cannot or will not provide informed consent for participation in the study

Outcomes

Primary Outcomes

Radiological analysis of radiolucency lines presence according to Gruen zone classification

Time Frame: 5 year

Secondary Outcomes

  • radiological assessment of femoral deformation(5 year, 10 year)
  • radiological assessment of femoral stem subsidence(5 year, 10 year)
  • radiological assessment of cortical bone density(5 year, 10 year)
  • radiological assessment of calcar resorption(5 year, 10 year)
  • Radiological analysis of radiolucency lines presence according to Gruen zone classification(10 year)

Study Sites (1)

Loading locations...

Similar Trials